The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index, and 2 are not checked yet.
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Abstract
The amyloid β protein is deposited in the brains of patients with Alzheimer's disease but its pathogenic role is unknown. In culture, the amyloid β protein was neurotrophic to undifferentiated hippocampal neurons at low concentrations and neurotoxic to mature neurons at higher concentrations. In differentiated neurons, amyloid β protein caused dendritic and axonal retraction followed by neuronal death. A portion of the amyloid β protein (amino acids 25 to 35) mediated both the trophic and toxic effects and was homologous to the tachykinin neuropeptide family. The effects of the amyloid β protein were mimicked by tachykinin antagonists and completely reversed by specific tachykinin agonists. Thus, the amyloid β protein could function as a neurotrophic factor for differentiating neurons, but at high concentrations in mature neurons, as in Alzheimer's disease, could cause neuronal degeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This Aβ peptide fragment contains the biologically active portion of Aβ (Yanker et al., 1990; Takadera et al., 1993).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Yanker et al., 1990
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The establishment of polarity by hippocampal neurons in culture.
Dotti, C., Sullivan, C., & Banker, G. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-04-01454.1988 · Cited by 1,862
Glutamate neurotoxicity in cortical cell culture
Choi, D. W., Maulucci-Gedde, M., & Kriegstein, A. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00357.1987 · Cited by 1,506
Rat hippocampal neurons in dispersed cell culture.
Banker, G. A., & Cowan, W. M. (1977) · Brain Research · doi:10.1016/0006-8993(77)90594-7 · Cited by 1,110
Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., & Beyreuther, K. T. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04000.x · Cited by 1,048
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Self-citationOutgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons
Mattson, M. P., Dou, P., & Kater, S. B. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-06-02087.1988 · Cited by 557
Maggio, J. E. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000305 · Cited by 550
Flagged first, then by citations
Research works printed but not linked: 2
- Dayhoff, M. O., Atlas of Protein Sequence and Structure 5 3: 345 (1978).
- GLENNER, G, BRANBURY REPORT 15: 137 (1983).
Cited by
Sorted by citations
Items 301–400 of 1,008
Alzheimer .beta.-Amyloid Peptide 25-35: Electrostatic Interactions with Phospholipid Membranes
Terzi, E., Hoelzemann, G., & Seelig, J. (1994) · Biochemistry · doi:10.1021/bi00189a051 · Cited by 172
Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
Kuboyama, T., Tohda, C., & Komatsu, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04664.x · Cited by 171
Giovannelli, L., Casamenti, F., Scali, C., Bartolini, L., & Pepeu, G. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00610-h · Cited by 170
Involvement of cytokines in acute neurodegeneration in the CNS
Rothwell, N. J., & Relton, J. K. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80152-6 · Cited by 169
Senile plaques in temporal lobe epilepsy
Mackenzie, I. R. A., & Miller, L. A. (1994) · Acta Neuropathologica · doi:10.1007/bf00294177 · Cited by 168
Wood, W. G., Eckert, G. P., Igbavboa, U., & Müller, W. E. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00025-7 · Cited by 168
Vil'ner, B. Y., de Costa, B., & Bowen, W. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00117.1995 · Cited by 168
Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 168
Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein
Verbeek, M. M., de Waal, R. M. W., Schipper, J. J., & Nostrand, W. E. V. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031135.x · Cited by 167
Das, S., & Potter, H. (1995) · Neuron · doi:10.1016/0896-6273(95)90300-3 · Cited by 167
Flood, J. F., Morley, J. E., & Roberts, E. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3363 · Cited by 167
Datki, Z., Juhász, A., Gálfi, M., Soós, K., Papp, R., Zádori, D., & Penke, B. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.09.011 · Cited by 166
MATTSON, M. P. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44401.x · Cited by 166
?-Amyloid formation by myocytes of leptomeningeal vessels
Wisniewski, H. M., & Węgiel, J. (1994) · Acta Neuropathologica · doi:10.1007/bf00296738 · Cited by 165
Ivins, K. J., Bui, E. T. N., & Cotman, C. W. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0228 · Cited by 164
β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity
Ii, M., Sunamoto, M., Ohnishi, K., & Ichimori, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00156-4 · Cited by 163
Greenberg, S. M., Koo, E. H., Selkoe, D. J., Qiu, W. Q., & Kosik, K. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7104 · Cited by 163
Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ
Goodwin, J. L., Uemura, E., & Cunnick, J. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00646-8 · Cited by 162
Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
Snow, W. M., & Albensi, B. C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00118 · Cited by 161
Fasae, K. D., Abolaji, A. O., Faloye, T. R., Odunsi, A., Oyetayo, B. O., Enya, J. I., Rotimi, J. A., Akinyemi, R., Whitworth, A. J., & Aschner, M. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126779 · Cited by 161
Zou, K., Kim, D. S., Kakio, A., Byun, K., Gong, J., Kim, J. W., Kim, M. J., Sawamura, N., Nishimoto, S., Matsuzaki, K., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02018.x · Cited by 160
Xiong, N., Dong, X., Zheng, J., Liu, F., & Sun, Y. P. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00915 · Cited by 160
Aluminium(III) as a promoter of cellular oxidation
Zatta, P. F., Kiss, T., Suwalsky, M., & Berthon, G. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00074-7 · Cited by 160
Pathogenesis of cerebral amyloid angiopathy
Rensink, A. A. M., de Waal, R. M. W., Kremer, B. P. H., & Verbeek, M. M. (2003) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.001 · Cited by 159
Fabiani, C., & Antollini, S. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00309 · Cited by 158
Freir, D. B., Hölscher, C., & Herron, C. E. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.708 · Cited by 157
Meda, L., Baron, P., Prat, E., Scarpini, E. A., Scarlato, G., Cassatella, M. A., & Rossi, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00188-x · Cited by 157
Genistein ameliorates β-amyloid peptide (25–35)-induced hippocampal neuronal apoptosis
Zeng, H., Chen, Q., & Zhao, B. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.018 · Cited by 157
LeBlanc, A. C. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07837.1995 · Cited by 157
Pike, C. J., Cummings, B. J., Monzavi, R., & Cotman, C. W. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90547-9 · Cited by 157
Mishizen-Eberz, A. J., Rissman, R. A., Carter, T. L., Ikonomovic, M. D., Wolfe, B. B., & Armstrong, D. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.016 · Cited by 156
Pereira, C., Santos, M. S., & Oliveira, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0241 · Cited by 156
Mattson, M. P. (1994) · Journal of Neurobiology · doi:10.1002/neu.480250409 · Cited by 156
Nagai, A., Nakagawa, E., Hatori, K., Choi, H. B., McLarnon, J. G., Lee, M. A., & Kim, S. U. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0437 · Cited by 156
Endothelial nitric oxide deficiency promotes Alzheimer’s disease pathology
Austin, S. A., Santhanam, A. V., Hinton, D. J., Choi, D., & Katusic, Z. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12334 · Cited by 155
Tomiyama, T., Asano, S., Furiya, Y., Shirasawa, T., Endo, N., & Mori, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34045-0 · Cited by 155
Perini, G., Bianca, V. D., Politi, V., Valle, G. D., Prà, I. D., Rossi, F., & Armato, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011797 · Cited by 155
Current and novel therapeutic molecules and targets in Alzheimer's disease
Kumar, A., Nisha, C. M., Silakari, C., Sharma, I., Anusha, K., Gupta, N., Nair, P., Tripathi, T., & Kumar, A. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.04.001 · Cited by 154
Zussy, C., Brureau, A., Delair, B., Marchal, S., Keller, E., IXART, G., Naert, G., Meunier, J., Chevallier, N., Maurice, T., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.021 · Cited by 154
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154
Zhu, Y. J., Lin, H., & Lal, R. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1244 · Cited by 153
Grace, E. A., Rabiner, C. A., & Busciglio, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00241-5 · Cited by 153
Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
Bharadwaj, P. R., Dubey, A. K., Masters, C. L., Martins, R. N., & Macreadie, I. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00609.x · Cited by 155
Reversible Random Coil-.beta.-Sheet Transition of the Alzheimer .beta.-Amyloid Fragment (25-35)
Terzi, E., Hoelzemann, G., & Seelig, J. (1994) · Biochemistry · doi:10.1021/bi00172a009 · Cited by 151
Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetesa
Lorenzo, A., & Yankner, B. A. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34406.x · Cited by 151
Self-citationFibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure
Soto, C. A., Castaño, E. M., Kumar, R., Beavis, R. C., & Frangione, B. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12089-m · Cited by 150
Zhang, C., Wei, W., Liu, Y., Peng, J.-H., Tian, Q., Liu, G., Zhang, Y., & Wang, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081036 · Cited by 150
Bodles, A. M., Guthrie, D. J. S., Greer, B., & Irvine, G. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00408.x · Cited by 149
Blanchard, B. J., Chen, A., Rozeboom, L. M., Stafford, K. A., Weigele, P., & Ingram, V. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405941101 · Cited by 149
Progressive brain dysfunction following intracerebroventricular infusion of beta1–42-amyloid peptide
Nakamura, S., Murayama, N., Noshita, T., Annoura, H., & Ohno, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02704-4 · Cited by 148
Pratt, B. M., & McPherson, J. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00018-x · Cited by 148
Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease
Geller, L. N., & Potter, H. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0236 · Cited by 147
β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth
Canning, D. R., McKeon, R. J., DeWitt, D. A., Perry, G. L., Wujek, J. R., Frederickson, R. C. A., & Silver, J. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1199 · Cited by 147
The neurotrophins and their receptors: Structure, function, and neuropathology
Maness, L. M., Kastin, A. J., Weber, J. T., Banks, W. A., Beckman, B. S., & Zadina, J. E. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90043-4 · Cited by 147
Getting to NO Alzheimer’s Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide
Balez, R., & Ooi, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3806157 · Cited by 149
Structure and function of amyloid in Alzheimer's disease
Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 146
The Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System
Masliah, E., & Terry, R. D. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00728.x · Cited by 145
Roher, A. E., Palmer, K. C., Yurewicz, E. C., Ball, M. J., & Greenberg, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09834.x · Cited by 144
Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 144
Effect of the Alzheimer amyloid fragment Aβ(25–35) on Akt/PKB kinase and survival of PC12 cells
Martı́n, D., Salinas, M., López‐Valdaliso, R., Serrano, E., Recuero, M., & Cuadrado, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00472.x · Cited by 142
Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 142
de Silva, H. A. R., Jen, A., Wickenden, C., Jen, L., Wilkinson, S. L., & Patel, A. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00045-4 · Cited by 141
Deposits of Amyloid β Protein in the Central Nervous System of Transgenic Mice
Wirak, D. O., Bayney, R. M., Ramabhadran, T. V., Fracasso, R. P., Hart, J., Hauer, P., Hsiau, P., Pekar, S. K., Scangos, G. A., Trapp, B. D., et al. (1991) · Science · doi:10.1126/science.1857970 · Cited by 141
Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 140
Thal, D. R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S., & Beckmann, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.017 · Cited by 138
Fraser, P. E., Nguyen, J. T., McLachlan, D. R. C., Abraham, C. R., & Kirschner, D. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03568.x · Cited by 138
Self-citationEckert, G. P., Cairns, N. J., Maras, A., Gattaz, W. F., & Müller, W. E. G. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017234 · Cited by 137
Preston, J. E., Hipkiss, A. R., Himsworth, D. T. J., Romero, I. A., & Abbott, J. N. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00058-5 · Cited by 137
In vitro aggregation facilitates β-amyloid peptide-(25–35)-induced amnesia in the rat
Delobette, S., Privat, A., & Maurice, T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00922-3 · Cited by 136
Haga, S., Ikeda, K., Sato, M., & Ishii, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91698-r · Cited by 136
Le, W., Colom, L. V., Xie, W., SMITH, R. G., Alexianu, M. E., & Appel, S. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00450-5 · Cited by 136
Ortega, R. H., Cerezo, A. B., de Pablos, R. M., Krisa, S., Richard, T., García-Parrilla, M. C., & Troncoso, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00373 · Cited by 136
Thal, D. R., Griffin, W. S. T., & Braak, H. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00411.x · Cited by 134
Pedersen, W. A., Kloczewiak, M. A., & Blusztajn, J. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8068 · Cited by 134
Zinc, Carnosine, and Neurodegenerative Diseases
Kawahara, M., Tanaka, K.-I., & Kato-Negishi, M. (2018) · Nutrients · doi:10.3390/nu10020147 · Cited by 134
Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
Puzzo, D., & Arancio, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129033 · Cited by 134
Shukla, V., Zheng, Y., Mishra, S. K., Amin, N. D., Steiner, J. P., Grant, P. G., Kesavapany, S., & Pant, H. C. (2012) · The FASEB Journal · doi:10.1096/fj.12-217497 · Cited by 134
Rampe, D., Wang, L., & Ringheim, G. E. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.014 · Cited by 134
Kar, S., Seto, D., Gaudreau, P., & Quirion, R. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01034.1996 · Cited by 134
Glucose metabolism and Alzheimer's disease
Schubert, D. A. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.02.003 · Cited by 133
Schubert, D. A., & Behl, C. (1993) · Brain Research · doi:10.1016/0006-8993(93)91331-l · Cited by 133
Synaptic remodeling during aging and in Alzheimer's disease
Masliah, E., Crews, L., & Hansen, L. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s311 · Cited by 132
Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus
Stepanichev, M. Y., Zdobnova, I. M., Zarubenko, I. I., Moiseeva, Y. V., Лазарева, Н. А., Onufriev, M. V., & Gulyaeva, N. V. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2003.11.003 · Cited by 132
Zinc Binding to Alzheimer's Aβ(1–16) Peptide Results in Stable Soluble Complex
Kozin, S. A., Zirah, S., Rebuffat, S., Hoa, G. H. B., & Debey, P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5284 · Cited by 131
Wang, R., Zhang, H., & Tang, X. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01030-5 · Cited by 131
Uetsuki, T., Takemoto, K., Nishimura, I., Okamoto, M., Niinobe, M., Momoi, T., Miura, M., & Yoshikawa, K. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06955.1999 · Cited by 131
Haass, C., Koo, E. H., Capell, A., Teplow, D. B., & Selkoe, D. J. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.4.537 · Cited by 131
Clementi, M. E., Marini, S., Coletta, M., Orsini, F., Giardina, B., & Misiti, F. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.041 · Cited by 131
Barnes, N. Y., Li, L., Yoshikawa, K., Schwartz, L. M., Oppenheim, R. W., & Milligan, C. E. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05869.1998 · Cited by 131
Gridley, K. E., Green, P. S., & Simpkins, J. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01056-1 · Cited by 131
Bancher, C., Jellinger, K., Lassmann, H., Fischer, P., & Leblhuber, F. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189115 · Cited by 130
Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila
Zhao, X.-L., Wang, W.-A., Tan, J.-X., Huang, J.-K., Zhang, X., Zhang, B.-Z., Wang, Y.-H., YangCheng, H.-Y., Zhu, H.-L., Sun, X.-J., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3699-09.2010 · Cited by 130
Kurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077624 · Cited by 130
Novarino, G. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1170-04.2004 · Cited by 130
Gan, L., Ye, S., Chu, A., Anton, K., Yi, S.-L., Vincent, V. A. M., von Schack, D., Chin, D. J., Murray, J. C., Lohr, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306183200 · Cited by 130
Brorson, J. R., Bindokas, V. P., Iwama, T., Marcuccilli, C. J., Chisholm, J. C., & Miller, R. J. (1995) · Journal of Neurobiology · doi:10.1002/neu.480260305 · Cited by 129
Emre, M., Geula, C., Ransil, B., & Mesulam, M. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90055-3 · Cited by 129
Casas, S., Novials, A., Reimann, F. M., Gomis, R., & Gribble, F. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1111-z · Cited by 128
The role of amyloid oligomers in neurodegenerative pathologies
Wells, C., Brennan, S. E., Keon, M., & Ooi, L. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.113 · Cited by 131
Rodrigues, C. M. P., Solá, S., Silva, R. F. M., & Brites, D. M. T. O. (2000) · Molecular Medicine · doi:10.1007/bf03401828 · Cited by 128
Metadata
- Authors
- Yankner, B. A., Duffy, L. K., & Kirschner, D. A.
- Affiliations
- Boston Children's Hospital (US)
- University of Alaska Fairbanks (US)
- Venue
- Science
- Published
- 1990-10-12
- Volume
- 250
- Issue
- 4978
- Pages
- 279-282
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2059214757
- Cited by
- 1,975
- References
- 31
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 15 · 2023: 22 · 2022: 14 · 2021: 29 · 2020: 19 · 2019: 29 · 2018: 32 · 2017: 27 · 2016: 37 · 2015: 44 · 2014: 46 · 2013: 40 · 2012: 40
- FWCI
- 64.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG08572, R01AG008572)
- National Institute of Neurological Disorders and Stroke (NS01240, K08NS001240)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, Alzheimer's disease, neurotoxicity, neurotrophic effects, tachykinin antagonists, hippocampal neurons, neuronal differentiation, neuronal cell death, dendritic retraction, axonal retraction, neurotrophic factors
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Embryo, Mammalian, Hippocampus, Molecular Sequence Data, Neurons, Neurotoxins, Peptide Fragments, Tachykinins, Amyloid beta-Peptides, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review